Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283167306> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4283167306 endingPage "A118" @default.
- W4283167306 startingPage "A118" @default.
- W4283167306 abstract "TYPE: Abstract TOPIC: Chest Infections PURPOSE: Procalcitonin has been used to differentiate between bacterial infections and other inflammatory processes in COVID-19. The goal of this study is to observe if procalcitonin use is associated with decreased duration of antibiotics and potential cost savings. Additionally, secondary objectives include if procalcitonin use is associated with ventilator changes, inflammatory markers, and mortality. METHODS: In this retrospective study, 287 patient records were selected based on the diagnosis of positive SARS-CoV-2 by PCR test and patients requiring mechanical ventilation. Lab values were obtained based on ventilator associated events (VAE) or sputum collections. RESULTS: There was no significant difference in those who received antibiotics between the procalcitonin cohort and non-procalcitonin cohort. The average duration of antibiotics was not statistically significant for vancomycin (2.2d v 1.8d), piperacillin-tazobactam (5.6d v 4d), azithromycin (2.7d v 2.5d), or meropenem (3d v 3.3d), between the procalcitonin and non-procalcitonin groups, respectively. Secondary outcomes were similarly not significant for ventilator changes and inflammatory markers. Lactic acid was lower in the procalcitonin group (1.8 v 3,1, p=0.01) along with overall 30-day mortality (45% v 76%, p=0.02). CONCLUSIONS: The use of procalcitonin did not have a significant correlation with duration of antibiotic use, ventilator changes, or inflammatory markers. Overall, the cost of inflammatory markers was approximated to be $377 daily, without reduction of antibiotic usage. CLINICAL IMPLICATIONS: The use of procalcitonin did not reduce antibiotic usage in the setting of COVID-19 ventilator-associated pneumonia and results in greater costs. DISCLOSURE: Nothing to declare. KEYWORD: procalcitonin" @default.
- W4283167306 created "2022-06-21" @default.
- W4283167306 creator A5013332603 @default.
- W4283167306 creator A5015967561 @default.
- W4283167306 creator A5031652756 @default.
- W4283167306 date "2022-06-01" @default.
- W4283167306 modified "2023-10-14" @default.
- W4283167306 title "COST ANALYSIS FOR USE OF PROCALCITONIN AND INFLAMMATORY MARKERS IN COVID-19 VENTILATOR-ASSOCIATED PNEUMONIA" @default.
- W4283167306 doi "https://doi.org/10.1016/j.chest.2021.12.150" @default.
- W4283167306 hasPublicationYear "2022" @default.
- W4283167306 type Work @default.
- W4283167306 citedByCount "0" @default.
- W4283167306 crossrefType "journal-article" @default.
- W4283167306 hasAuthorship W4283167306A5013332603 @default.
- W4283167306 hasAuthorship W4283167306A5015967561 @default.
- W4283167306 hasAuthorship W4283167306A5031652756 @default.
- W4283167306 hasBestOaLocation W42831673061 @default.
- W4283167306 hasConcept C10936531 @default.
- W4283167306 hasConcept C126322002 @default.
- W4283167306 hasConcept C167135981 @default.
- W4283167306 hasConcept C177713679 @default.
- W4283167306 hasConcept C2777080012 @default.
- W4283167306 hasConcept C2777184939 @default.
- W4283167306 hasConcept C2777914695 @default.
- W4283167306 hasConcept C2778384902 @default.
- W4283167306 hasConcept C501593827 @default.
- W4283167306 hasConcept C71924100 @default.
- W4283167306 hasConcept C72563966 @default.
- W4283167306 hasConcept C86803240 @default.
- W4283167306 hasConcept C89423630 @default.
- W4283167306 hasConceptScore W4283167306C10936531 @default.
- W4283167306 hasConceptScore W4283167306C126322002 @default.
- W4283167306 hasConceptScore W4283167306C167135981 @default.
- W4283167306 hasConceptScore W4283167306C177713679 @default.
- W4283167306 hasConceptScore W4283167306C2777080012 @default.
- W4283167306 hasConceptScore W4283167306C2777184939 @default.
- W4283167306 hasConceptScore W4283167306C2777914695 @default.
- W4283167306 hasConceptScore W4283167306C2778384902 @default.
- W4283167306 hasConceptScore W4283167306C501593827 @default.
- W4283167306 hasConceptScore W4283167306C71924100 @default.
- W4283167306 hasConceptScore W4283167306C72563966 @default.
- W4283167306 hasConceptScore W4283167306C86803240 @default.
- W4283167306 hasConceptScore W4283167306C89423630 @default.
- W4283167306 hasIssue "6" @default.
- W4283167306 hasLocation W42831673061 @default.
- W4283167306 hasLocation W42831673062 @default.
- W4283167306 hasOpenAccess W4283167306 @default.
- W4283167306 hasPrimaryLocation W42831673061 @default.
- W4283167306 hasRelatedWork W1853252233 @default.
- W4283167306 hasRelatedWork W2009263326 @default.
- W4283167306 hasRelatedWork W2109951587 @default.
- W4283167306 hasRelatedWork W2133776215 @default.
- W4283167306 hasRelatedWork W2138470825 @default.
- W4283167306 hasRelatedWork W2162207945 @default.
- W4283167306 hasRelatedWork W2376286557 @default.
- W4283167306 hasRelatedWork W2410854040 @default.
- W4283167306 hasRelatedWork W3032635361 @default.
- W4283167306 hasRelatedWork W3108455974 @default.
- W4283167306 hasVolume "161" @default.
- W4283167306 isParatext "false" @default.
- W4283167306 isRetracted "false" @default.
- W4283167306 workType "article" @default.